Approach to Monitoring Initial and Subsequent Antiretroviral Therapy - Flowchart
Approach to Monitoring Initial and Subsequent Antiretroviral Therapy - Flowchart HIV Infection & AIDS: Treatment HIV Infection & AIDS: Treatment
«Flowchart»

Repeatedly positive ELISA and Western blot confirmation of HIV

Repeatedly positive ELISA and Western blot confirmation of HIV

Repeatedly positive ELISA and Western blot confirmation of HIV

Change to alternative drug or regimen

Change to alternative drug or regimen

Change to alternative drug or regimen

Assess adherence. If not adherent, initiate adherence counseling. If adherent, or if prolonged period of partial or nonadherence.

Assess adherence. If not adherent, initiate adherence counseling. If adherent, or if prolonged period of partial or nonadherence.

Assess adherence. If not adherent, initiate adherence counseling. If adherent, or if prolonged period of partial or nonadherence.

Perform resistance testing and change to a regimen with three drugs to which the patient is not resistant from at least two different classes.

Perform resistance testing and change to a regimen with three drugs to which the patient is not resistant from at least two different classes.

Perform resistance testing and change to a regimen with three drugs to which the patient is not resistant from at least two different classes.

End

End

End

Perform HIV viral load and resistance testing and begin a recommended antiretroviral treatment regimen (Table 33–9)

Perform HIV viral load and resistance testing and begin a recommended antiretroviral treatment regimen (Table 33–9)

Perform HIV viral load and resistance testing and begin a recommended antiretroviral treatment regimen (Table 33–9)

Intolerance to regimen

Intolerance to regimen

Intolerance to regimen

Viral load detectable after 4–12 weeks of treatment or viral rebound after suppression

Viral load detectable after 4–12 weeks of treatment or viral rebound after suppression

Viral load detectable